ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2635

Validating Arthroscopic Findings Using Histology, Status for Erosive Disease, and CRP in RA

Carl Orr1, Trudy McGarry2, Francis Young3, Ursula Fearon2 and Douglas J. Veale1, 1St Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, Dublin 4, Ireland, 2St. Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, Dublin 4, Ireland, 3Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, Dublin 4, Ireland

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Arthroscopy, C Reactive Protein, histopathologic and radiography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

The utility of synovial biopsy has been confirmed as an important research tool in increasing our understanding of the pathogenesis of RA, evaluating new treatments and identifying potential therapeutic targets.[1, 2]  However, no scoring system for the assessment of synovitis at knee arthroscopy has been validated against the histological grade of inflammation observed in the synovial biopsies retrieved.

Furthermore, the power that arthroscopy may have in identifying patients with active inflammation despite normal CRPs has not been reported. Finally, we currently understand only 32% of the variance in factors that predict joint destruction,[3] and macroscopic findings at arthroscopy may present an additional opportunity in assessing those most at risk of this disease course.

Aims

To validate synovitis scores at arthroscopy with histology scores, CRP levels and erosive disease on radiographs.

Methods:

141 patients with RA were recruited to undergo arthroscopy, and serum CRP levels were measured at the same time. The most recent set of hands and feet radiographs were assessed for the presence or absence of erosions. A macroscopic score of synovitis, graded at 5 unit intervals between 0-100, was recorded by the operator at each arthroscopy.

Synovitis scores were analysed using Pearson’s test for correlation, with categorical data for histology findings (no inflammation, mild inflammation, and moderate-severe inflammation).The same test was used to determine if there was a correlation between synovitis scores and CRP levels.

The Chi-square test was employed to test for a relationship between categorical synovitis scores (4 quartiles), and the presence or absence of erosions.

Results:

A correlation was observed between synovitis scores and histology findings (p=0.0014, r=0.2943).

There was no correlation with synovitis scores and CRP levels. 49 (34.8%) patients had normal CRP levels (0-5mg/l), with 29 (59.2%) having synovitis scores >50%.

An association was also observed with higher synovitis scores and the presence of erosions (p=0.0173).

Conclusion:

Synovitis can be reliably assessed by scores at arthroscopy, which correlate with subsequent histological findings. Arthroscopy has the power to identify patients with synovitis, where CRP levels are normal, favouring the concept that not all RA phenotypes manifest elevated CRP levels during active disease. Furthermore, those with high synovitis scores are more likely to have erosions on  radiographs.

1.            Gerlag DM, Tak PP. Novel approaches for the treatment of rheumatoid arthritis: Lessons from the evaluation of synovial biomarkers in clinical trials. Best Practice & Research Clinical Rheumatology 22(2), 311-323 (2008).

2.            Kraan MC, et al. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis: Findings in a prospective, randomized, double‐blind, parallel‐design clinical trial in thirty‐nine patients at two centers. Arthritis & Rheumatism 43(8), 1820-1830 (2000).

3.            De Rooy DP, et al. Predicting arthritis outcomes–what can be learned from the leiden early arthritis clinic? Rheumatology (Oxford, England) 50(1), 93-100 (2011).


Disclosure: C. Orr, None; T. McGarry, None; F. Young, None; U. Fearon, None; D. J. Veale, None.

To cite this abstract in AMA style:

Orr C, McGarry T, Young F, Fearon U, Veale DJ. Validating Arthroscopic Findings Using Histology, Status for Erosive Disease, and CRP in RA [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/validating-arthroscopic-findings-using-histology-status-for-erosive-disease-and-crp-in-ra/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validating-arthroscopic-findings-using-histology-status-for-erosive-disease-and-crp-in-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology